Toward personalized therapy in AML: In vivo benefit of targeting aberrant epigenetics in MLL-PTD-associated AML

K. M. Bernot, R. F. Siebenaler, S. P. Whitman, N. A. Zorko, G. G. Marcucci, R. Santhanam, E. H. Ahmed, M. Ngangana, K. K. McConnell, J. S. Nemer, D. L. Brook, S. K. Kulp, C. S. Chen, D. Frankhouser, P. Yan, R. Bundschuh, X. Zhang, A. M. Dorrance, K. E. Dickerson, D. JarjouraW. Blum, G. Marcucci, M. A. Caligiuri

Research output: Contribution to journal › Letter › peer-review

12 Scopus citations

Fingerprint

Dive into the research topics of 'Toward personalized therapy in AML: In vivo benefit of targeting aberrant epigenetics in MLL-PTD-associated AML'. Together they form a unique fingerprint.